Citigroup’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$64.6M Buy
923,998
+135,107
+17% +$9.44M 0.03% 372
2025
Q1
$58M Sell
788,891
-34,233
-4% -$2.52M 0.03% 378
2024
Q4
$53.9M Sell
823,124
-721,238
-47% -$47.3M 0.03% 326
2024
Q3
$120M Buy
1,544,362
+108,617
+8% +$8.46M 0.07% 173
2024
Q2
$112M Buy
1,435,745
+570,510
+66% +$44.5M 0.07% 180
2024
Q1
$58.6M Buy
865,235
+196,291
+29% +$13.3M 0.04% 294
2023
Q4
$45.1M Sell
668,944
-63,977
-9% -$4.31M 0.03% 338
2023
Q3
$49.6M Buy
732,921
+53,536
+8% +$3.63M 0.04% 294
2023
Q2
$48.6M Sell
679,385
-558,120
-45% -$39.9M 0.03% 317
2023
Q1
$85.9M Buy
1,237,505
+305,420
+33% +$21.2M 0.06% 179
2022
Q4
$63.2M Buy
932,085
+417,526
+81% +$28.3M 0.05% 237
2022
Q3
$28.2M Buy
514,559
+145,093
+39% +$7.96M 0.02% 435
2022
Q2
$24.4M Sell
369,466
-183,275
-33% -$12.1M 0.02% 496
2022
Q1
$36.7M Buy
552,741
+53,529
+11% +$3.55M 0.02% 428
2021
Q4
$29.1M Sell
499,212
-214,886
-30% -$12.5M 0.02% 544
2021
Q3
$42.9M Sell
714,098
-11,304,880
-94% -$679M 0.03% 414
2021
Q2
$720M Buy
12,018,978
+6,232,903
+108% +$373M 0.43% 20
2021
Q1
$288M Buy
5,786,075
+2,332,942
+68% +$116M 0.19% 73
2020
Q4
$173M Buy
3,453,133
+3,009,374
+678% +$150M 0.1% 109
2020
Q3
$24.3M Buy
443,759
+86,348
+24% +$4.73M 0.02% 510
2020
Q2
$18.9M Sell
357,411
-25,223
-7% -$1.33M 0.01% 532
2020
Q1
$17.1M Buy
382,634
+94,505
+33% +$4.22M 0.02% 475
2019
Q4
$14.4M Buy
288,129
+41,577
+17% +$2.07M 0.01% 679
2019
Q3
$11M Buy
246,552
+7,414
+3% +$330K 0.01% 755
2019
Q2
$9.87M Buy
239,138
+59,127
+33% +$2.44M 0.01% 820
2019
Q1
$7.28M Sell
180,011
-6,283
-3% -$254K 0.01% 843
2018
Q4
$7.08M Buy
186,294
+67,753
+57% +$2.57M 0.01% 847
2018
Q3
$4.69M Sell
118,541
-79,116
-40% -$3.13M ﹤0.01% 1039
2018
Q2
$6.94M Buy
197,657
+27,935
+16% +$981K 0.01% 885
2018
Q1
$5.94M Sell
169,722
-213,459
-56% -$7.46M ﹤0.01% 897
2017
Q4
$13.3M Buy
383,181
+260,515
+212% +$9.04M 0.01% 566
2017
Q3
$4.16M Sell
122,666
-21,088
-15% -$714K ﹤0.01% 1058
2017
Q2
$4.9M Buy
143,754
+18,999
+15% +$648K ﹤0.01% 953
2017
Q1
$3.88M Sell
124,755
-423,458
-77% -$13.2M ﹤0.01% 1034
2016
Q4
$15M Buy
548,213
+447,549
+445% +$12.2M 0.01% 492
2016
Q3
$3.31M Sell
100,664
-52,825
-34% -$1.74M ﹤0.01% 1112
2016
Q2
$4.63M Sell
153,489
-24,372
-14% -$736K ﹤0.01% 838
2016
Q1
$5.01M Buy
177,861
+71,992
+68% +$2.03M 0.01% 828
2015
Q4
$3.59M Sell
105,869
-73,040
-41% -$2.48M ﹤0.01% 1060
2015
Q3
$5.69M Sell
178,909
-106,995
-37% -$3.4M 0.01% 802
2015
Q2
$9.11M Buy
285,904
+225,222
+371% +$7.17M 0.01% 628
2015
Q1
$2.08M Sell
60,682
-81,160
-57% -$2.78M ﹤0.01% 1323
2014
Q4
$4.99M Sell
141,842
-49,472
-26% -$1.74M ﹤0.01% 831
2014
Q3
$6.83M Sell
191,314
-168,712
-47% -$6.03M 0.01% 733
2014
Q2
$13.4M Buy
360,026
+282,088
+362% +$10.5M 0.01% 502
2014
Q1
$2.53M Sell
77,938
-178,528
-70% -$5.79M ﹤0.01% 1126
2013
Q4
$7.61M Buy
256,466
+171,966
+204% +$5.11M 0.01% 702
2013
Q3
$2.19M Sell
84,500
-21,188
-20% -$550K ﹤0.01% 1208
2013
Q2
$2.5M Buy
+105,688
New +$2.5M ﹤0.01% 1179